Open AccessSaudi experience in the management of pulmonary arterial hypertension; the outcome of PAH therapy with the exclusion of chronic parenteral prostacyclin
Author(s) -
Majdy Idrees,
Khalid Alnajashi,
Jasim Abdulhameed,
Atika Khan,
Enas Batubara,
Abdelmajeed Alotay,
Amel Fayed,
Saleh Aldammas,
Moaad Alseif,
Husam Alawwad,
Yahya Abusabaa,
Mashael Almobrad,
Tarek Kashour
Publication year - 2015
Publication title -
annals of thoracic medicine (online)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.639
H-Index - 33
eISSN - 1817-1737
pISSN - 1998-3557
DOI - 10.4103/1817-1737.160842
Subject(s) - medicine , pulmonary hypertension , cohort , portopulmonary hypertension , prostacyclin , combination therapy , gastroenterology , cohort study , cardiology , portal hypertension , cirrhosis
The purpose of this study is to present our center's experience in managing patients with pulmonary arterial hypertension (PAH). The main objective is to describe patients' management profile and treatment outcome.